Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Fact Sheet  (NTPH)



Big Opportunity: Golden Decade of Defence Stocks in India


Here is the latest financial fact sheet of NATCO PHARMA. For more details, see the NATCO PHARMA quarterly results and NATCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

NATCO PHARMA Price History

Price Rs 546.7
Mkt Cap Rs m 99,804
Vol '000 5.7
P/E X 25.7
P/CF X 31.9
EPS (TTM) Rs 21.3
1 Day % 1.4
No. of shares m 182.56
1 Week % 0.5
1 Month % -0.5
1 Year % -32.4
52 week H/L Rs 846.7/502.0
As on Mar 21, 2023 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NATCO PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
NATCO PHARMA EQUITY SHARE DATA
High Rs1,0808497389951,189 
Low Rs671557450492750 
Sales per share (Unadj.) Rs117.5114.6105.2112.5106.6 
Earnings per share (Unadj.) Rs37.735.225.224.39.3 
Diluted earnings per shareRs38.135.225.124.29.3 
Cash flow per share (Unadj.) Rs41.339.630.630.717.1 
Dividends per share (Unadj.) Rs8.256.256.755.254.50 
Adj. dividends per shareRs8.346.266.735.244.50 
Avg Dividend yield %0.90.91.10.70.5 
Book value per share (Unadj.) Rs165.2189.2206.0225.1233.4 
Adj. book value per shareRs167.0189.4205.4224.8233.4 
Shares outstanding (eoy) m184.49182.75182.07182.34182.52 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x7.56.15.66.69.1 
Avg P/E ratio x23.220.023.630.6104.1 
P/CF ratio (eoy) x21.217.819.424.256.6 
Price / Book Value ratio x5.33.72.93.34.2 
Dividend payout %21.917.826.821.648.3 
Avg Mkt Cap Rs m161,547128,471108,130135,564176,990 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,2563,5593,7504,1494,448 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
NATCO PHARMA INCOME DATA
Net Sales Rs m21,67620,94519,15020,52119,448 
Other income Rs m4041,3021,0741,060990 
Total revenues Rs m22,08022,24720,22421,58120,438 
Gross profit Rs m9,2847,9485,8266,0382,635 
Depreciation Rs m6628109981,1691,426 
Interest Rs m154193215133177 
Profit before tax Rs m8,8728,2475,6875,7962,022 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,9201,8231,1061,372322 
Profit after tax Rs m6,9526,4244,5814,4241,700 
Gross profit margin %42.837.930.429.413.5 
Effective tax rate %21.622.119.423.715.9 
Net profit margin %32.130.723.921.68.7 
NATCO PHARMA BALANCE SHEET DATA
Current assets Rs m21,30723,47223,25623,44824,972 
Current liabilities Rs m5,9207,2876,8535,2567,104 
Net working cap to sales %71.077.385.788.791.9 
Current ratio x3.63.23.44.53.5 
Inventory Days Days2642366370 
Debtors Days Days1078810573116 
Net fixed assets Rs m15,84419,55922,62224,47126,119 
Share capital Rs m369365364365365 
"Free" reserves Rs m30,11434,21737,13640,67642,237 
Net worth Rs m30,48334,58237,50041,04142,602 
Long term debt Rs m00900 
Total assets Rs m37,15143,03145,87847,91951,091 
Interest coverage x58.643.727.544.612.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.60.50.40.40.4 
Return on assets %19.115.410.59.53.7 
Return on equity %22.818.612.210.84.0 
Return on capital %29.624.415.714.45.2 
Exports to sales %00000 
Imports to sales %13.714.09.510.920.0 
Exports (fob) Rs m00000 
Imports (cif) Rs m2,9782,9391,8182,2313,882 
Fx inflow Rs m10,32211,5368,73611,1948,881 
Fx outflow Rs m2,9782,9391,8182,2313,882 
Net fx Rs m7,3438,5976,9188,9634,999 
NATCO PHARMA CASH FLOW
From Operations Rs m 4,636 6,688 4,173 2,988 465 
From Investments Rs m -11,155 -6,122 -1,670 -1,033 -53 
From Financial Activity Rs m 6,509 -509 -2,508 -1,857 348 
Net Cashflow Rs m -18 66 -85 60 853 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 48.8%
Institution 26.7%
Non-Institution 24.5%
Total 100.0%
Free Float 51.2%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2022
 

Company Information

Regd Off Natco House, Road No 2, Banjara Hills, Hyderabad - 500003
E-mail investors@natcopharma.co.in Web www.natcopharma.co.in
Tel 040-23547532 Fax 040-23548243
Sector PHARMACEUTICALS Group Natco
Tr Agent Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
Auditor Walker, Chandiok & Co.
CHM: G S Murthy COMP SEC: Chekuri Venkat Ramesh YEAR OF INC: 1981 BSE CODE: 524816 FV (Rs): 2 DIV YIELD (%): 0.8

Read: NATCO PHARMA 2021-22 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   CIPLA    AUROBINDO PHARMA    PIRAMAL ENTERPRISES    LUPIN    SUN PHARMA    

Compare NATCO PHARMA With:   CIPLA    AUROBINDO PHARMA    PIRAMAL ENTERPRISES    LUPIN    SUN PHARMA    




Today's Market

Sensex Today Zooms 446 Points, Nifty Above 17,100 | Reliance & Titan Surge 3% | Power Grid & HUL Down 2% Sensex Today Zooms 446 Points, Nifty Above 17,100 | Reliance & Titan Surge 3% | Power Grid & HUL Down 2%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum throughout the trading session and ended on a firm footing.